RSLS News and Press, ReShape Lifesciences Inc. From 11/06/23

IRVINE, Calif., Nov. 06, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that it will report its financial results for the third quarter ended September 30, 2023, including...

2023-10-25 13:19:48 ET DENVER, Colo., Oct. 25, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; BioXcel Therapeutics Inc (NASDAQ: BTAI), Abri SPAC I Inc (NASDAQ: ASPA), Deutsche Bank AG (NYSE: DB), ...

2023-10-25 09:59:18 ET DENVER, Colo., Oct. 25, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; BioXcel Therapeutics Inc (NASDAQ: BTAI), Abri SPAC I Inc (NASDAQ: ASPA), Deutsche Bank AG (NYSE: DB), Pagaya ...

2023-10-25 07:14:40 ET DENVER, Colo., Oct 25, 2023 ( www.247marketnews.com )- Reshape Lifesciences Inc (NASDAQ: RSLS) is trading at $0.279, up $0.19 (+212.56%), on 27.29M premarket shares traded. Its 52-week range is $0.1856 to $22.40. This hit a new 52-week low on Monday and 34-cen...

2023-10-17 12:08:30 ET More on Johnson & Johnson Johnson & Johnson: A Conservative High-Yield Dividend Aristocrat Buy Johnson & Johnson Q3 Earnings Preview: Don't Count On Different Proposition Post Kenvue Spin-Out Johnson & Johnson: The Bull Case Can...

2023-10-12 10:01:47 ET DENVER, Colo., Oct. 12, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Jaguar Health (NASDAQ: JAGX), LL Flooring Holdings (NYSE: LL), Secoo Holding (NASDAQ: SECO), OpGen (NASDAQ: O...

2023-10-02 05:29:59 ET More on ReShape Lifesciences ReShape Lifesciences Inc. (RSLS) Q2 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on ReShape Lifesciences Historical earnings data for ReShape Lifesciences Financial information for ReSha...

IRVINE, Calif., Sept. 29, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences ® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced the pricing of its public offering of 9,100,000 units, with each unit consisting of one share of common ...

IRVINE, Calif., Sept. 22, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that Paul F. Hickey, President and Chief Executive Officer, and Tom Stankovich, Chief Financia...

IRVINE, Calif., Sept. 21, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced the signing of an exclusive, royalty-bearing license agreement with Biorad Medysis, Pvt. Ltd. ...